Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Share Buyback Programme

17 Sep 2019 07:00

RNS Number : 5232M
Redcentric PLC
17 September 2019
 

17 September 2019

Redcentric plc

("Redcentric" or the "Company")

 

 Share Buyback Programme

 

Redcentric plc (AIM: RCN) announces that it has approved a share buyback programme of ordinary shares of 0.1p in the capital of the Company ("Ordinary Shares") for an aggregate purchase price of up to £2 million (the "Buyback Programme"). The Buyback Programme forms part of the Group's broader strategy to deliver shareholder value.

 

The Buyback Programme will be independently managed by finnCap Ltd, the Company's joint broker, which will make trading decisions independently and without the influence of the Company.

 

The Buyback Programme is in accordance with the terms of the Company's authority to make market purchases of its own Ordinary Shares which was granted at the Company' Annual General Meeting on 2 September 2019 (the "Authority"). The maximum price paid per Ordinary Share is to be no more than 105 per cent. of the average middle market closing price of an Ordinary Share for the five business days preceding the date of purchase. The Buyback Programme will commence today and will continue until such time that the board of directors of the Company decides to end the Buyback Programme, at which point a further announcement will be made by the Company.

 

Any Ordinary Shares acquired as a result of the Buyback Programme will be held in treasury and be announced to the market without delay.

 

Due to the limited liquidity in the issued Ordinary Shares, any Buyback of Ordinary Shares pursuant to the Authority on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on AIM and may exceed 25 per cent. of the average daily trading volume, being the limit laid down in Article 5(1) of Regulation (EU) No 596/2014 and, accordingly, the Company will not benefit from the exemption contained in this Article.

 

The Company confirms that it currently has no other unpublished price sensitive information other than what has been disclosed above.

 

 Enquiries:

 

Redcentric plc

 

Peter Brotherton, Chief Executive Officer

Via Tulchan

Dean Barber, Chief Financial Officer

 

 

 

Tulchan

+44 (0)20 7353 4200

James Macey White / Matt Low

 

 

 

Numis Securities Limited - Nomad and Joint Broker

+44 (0)20 7260 1000

Simon Willis / Oliver Hardy

 

 

 

finnCap Ltd - Joint Broker

+44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

 

 

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSFMGMLLVVGLZM
Date   Source Headline
1st Oct 20203:15 pmRNSForm 8.3 - Redcentric PLC
1st Oct 20207:00 amRNSRule 2.9 Announcement
1st Oct 20207:00 amRNSExercise of Options
28th Sep 20202:42 pmRNSForm 8.3 - Redcentric PLC
28th Sep 20207:00 amRNSRule 2.9 Announcement
28th Sep 20207:00 amRNSRestitution Scheme Update
25th Sep 20203:00 pmRNSForm 8.3 - Redcentric PLC
25th Sep 202010:21 amRNSForm 8.3 - Redcentric PLC
24th Sep 20202:49 pmRNSForm 8.3 - Redcentric PLC
23rd Sep 20202:45 pmRNSForm 8.3 - Redcentric PLC
17th Sep 20207:00 amRNSForm 8.3 - Redcentric plc
16th Sep 20202:49 pmRNSResult of AGM
16th Sep 202010:56 amRNSForm 8 (OPD) - SIX DEGREES HOLDINGS LIMITED
14th Sep 202011:30 amRNSRule 2.9 Announcement
14th Sep 202011:30 amRNSRestitution Scheme Update
14th Sep 20208:44 amRNSForm 8.3 - Redcentric Plc
9th Sep 20206:28 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:26 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:24 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:23 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:23 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:22 pmRNSForm 8.3 - Redcentric PLC
7th Sep 202012:57 pmRNSGranite Growth 169 LLC Form 8.3 - Redcentric Plc
7th Sep 20207:00 amRNSForm 8 (OPD) - Redcentric plc
4th Sep 20204:37 pmRNSForm 8.3 - Redcentric PLC
4th Sep 20209:08 amRNSForm 8.3 - Redcentric Plc
4th Sep 20208:55 amRNSForm 8.3 - Redcentric Plc
3rd Sep 20205:35 pmRNSForm 8.3 - Redcentric Plc
3rd Sep 20204:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20204:33 pmRNSForm 8.3 - Redcentric plc
3rd Sep 20201:15 pmRNSForm 8 (OPD) - Redcentric PLC
3rd Sep 202012:00 pmRNSForm 8.5 (EPT/RI) - Redcentric Plc
3rd Sep 20209:07 amRNSForm 8.3 - Redcentric PLC
3rd Sep 20208:30 amRNSRule 2.9 Announcement
2nd Sep 20207:00 amRNSResponse to press speculation-formal sales process
1st Sep 20208:30 amRNSRestitution Scheme Update
1st Sep 20207:00 amRNSSave As You Earn Share Option Scheme
24th Aug 202010:23 amRNSRestitution Scheme Update
17th Aug 20202:45 pmRNSRestitution Scheme Update
11th Aug 20207:00 amRNSPublication of Annual Report and Notice of AGM
11th Aug 20207:00 amRNSRestitution Scheme Update
29th Jul 20207:00 amRNSIssue of Equity and Total Voting Rights
21st Jul 20207:00 amRNSPreliminary Results Announcement FY20
13th Jul 20201:19 pmRNSGeneral Meeting Result, Voting Rights & Admission
26th Jun 202010:07 amRNSAdditional Voting Support
26th Jun 20207:00 amRNSProposed Restitution Scheme and Placing
26th Jun 20207:00 amRNSTrading Update and Results Date
19th Jun 20207:00 amRNSDelay of Full Year Results
9th Jun 20207:00 amRNSExtension of bank facilities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.